about
Epigenetic alterations of the Wnt signaling pathway in cancer: a mini reviewApocrine carcinoma of the breast: A brief update on the molecular features and targetable biomarkersMammary Analogue Secretory Carcinoma (MASC) of the salivary gland: A new tumor entity.Hamartomas, teratomas and teratocarcinosarcomas of the head and neck: Report of 3 new cases with clinico-pathologic correlation, cytogenetic analysis, and review of the literatureComprehensive tumor profiling identifies numerous biomarkers of drug response in cancers of unknown primary site: analysis of 1806 cases.Cystic fibroepithelioma of Pinkus: two new cases and cystic changes in classical fibroepithelioma of Pinkus.Update on the molecular profile of the MDA-MB-453 cell line as a model for apocrine breast carcinoma studiesER-α36, a novel isoform of ER-α66, is commonly over-expressed in apocrine and adenoid cystic carcinomas of the breast.PD-L1 Status in Refractory Lymphomas.Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1.Infarcted fibroadenoma of the breast: report of two new cases with review of the literature.Multiplatform molecular profiling identifies potentially targetable biomarkers in malignant phyllodes tumors of the breast.A review of adenoid cystic carcinoma of the breast with emphasis on its molecular and genetic characteristics.Neonatal hyperimmune T-cell reaction mimicking T-cell non-Hodgkin's lymphoma following BCG and hepatitis B co-vaccination.Aggressive and nonaggressive translocation t(6;11) renal cell carcinoma: comparative study of 6 cases and review of the literature.Assessment of HER2 gene status in breast carcinomas with polysomy of chromosome 17.Regulated cell death in diagnostic histopathology.Does everything a surgeon takes out have to be seen by a pathologist? A review of the current pathology practice.High microsatellite instability (MSI-H) colorectal carcinoma: a brief review of predictive biomarkers in the era of personalized medicineComprehensive profiling of metaplastic breast carcinomas reveals frequent overexpression of programmed death-ligand 1.Solid papillary renal cell carcinoma: clinicopathologic, morphologic, and immunohistochemical analysis of 10 cases and review of the literature.Warthin-like papillary renal cell carcinoma: Clinicopathologic, morphologic, immunohistochemical and molecular genetic analysis of 11 cases.Skeletal Muscle Metastases from Squamous Cell Carcinoma of the Cervix: Report of Two Cases With Literature Review.The reality of cancer treatment in a developing country: the effects of delayed TKI treatment on survival, cytogenetic and molecular responses in chronic myeloid leukaemia patients.An Essential Role of Maspin in Embryogenesis and Tumor Suppression.Expression and prognostic value of putative cancer stem cell markers CD117 and CD15 in choroidal and ciliary body melanoma.Predictive Biomarker Profiling of > 6000 Breast Cancer Patients Shows Heterogeneity in TNBC, With Treatment Implications.Microsatellite instability status predicts response to anti-PD-1/PD-L1 therapy regardless the histotype: A comment on recent advances.Adenoid cystic carcinomas of the breast have low Topo IIα expression but frequently overexpress EGFR protein without EGFR gene amplification.Immunohistochemical and molecular profiling of histologically defined apocrine carcinomas of the breast.IMP3, a proposed novel basal phenotype marker, is commonly overexpressed in adenoid cystic carcinomas but not in apocrine carcinomas of the breast.Hereditary breast cancer: part II. Management of hereditary breast cancer: implications of molecular genetics and pathology.Novel intronic germline FLCN gene mutation in a patient with multiple ipsilateral renal neoplasms.The Bcl-2 protein: a prognostic indicator strongly related to ER and PR in breast cancer.Programmed cell death 1 (PD-1) and its ligand (PD-L1) in common cancers and their correlation with molecular cancer type.Immunohistochemical evaluation of cyclin D1 in breast cancer.Extraskeletal myxoid chondrosarcoma of the vulva with PLAG1 gene activation: molecular genetic characterization of 2 cases.Novel regulators of PD-L1 expression in cancer: CMTM6 and CMTM4-a new avenue to enhance the therapeutic benefits of immune checkpoint inhibitors.The role of the Hedgehog signaling pathway in cancer: A comprehensive review.Whorling cellular perineurioma: A previously undescribed variant closely mimicking monophasic fibrous synovial sarcoma.
P50
Q26824835-9CAF8167-5FCD-4A07-A543-099781361376Q28079858-8E6B374A-CB47-4197-8D4F-C58CCCAC1655Q30251463-6E81FE1C-507E-4E13-8409-4DCDB04B46DDQ33386259-00607B97-A01E-44F6-B032-E26A09DC9327Q35068021-C5EE4F7F-B3E8-4BAF-9052-337B1A5A5A98Q35099874-EA160D76-500A-4F99-8F29-308C0DB995A2Q35573116-8E9D6C34-3FAE-46D4-B835-989F22697EF1Q36048992-4BDD202C-F731-4ADC-A5E4-5E299B9BCF7FQ36197517-B5A10280-A92D-4950-925B-0D44AC389C77Q36260647-CFAA3FFA-C9CA-45E9-9589-9F3BDA0B22C5Q36686555-294898BC-4F06-49B8-95DF-1DA8C2DA55C1Q36738945-1549717E-FDDD-4D03-BCE8-6C9C10816083Q38004209-950B29B2-5EEF-435B-83F6-2535E27D7212Q38042581-EF03EEB6-6D8E-4388-841A-64EAC3F9EF4AQ38273455-5DD1CA2B-D629-4DA6-BD17-525D1C8D8DC7Q38414983-59F5854F-0BEE-4C45-9317-2459125EEDAAQ38502159-0B856221-12DE-484C-A275-9B44643F3447Q38544093-9C232826-A8BA-46A2-957A-B9F778250C0FQ38732716-68FA660A-1526-47CF-A5D9-E5C18DF78DD0Q38830663-D55416EE-B0E9-45C8-B1D8-BD18AA0EA945Q38840969-D5C9E0EE-C0EF-482B-A889-0A7542FDC6D1Q38888987-49491B7C-EAE9-4611-AEB1-D787ED30D508Q38890091-D9FEF6DD-E357-44EF-873C-8978E5240982Q40337682-5AC1D341-DD09-43AE-AAD5-2DBC77BD3231Q40421307-CB10BB3B-C3EA-41CF-906E-CBA640B3F53AQ41468611-618865A0-A9F0-4927-AED0-CBE57F7DE672Q41688279-89207202-7848-44AF-A37E-176BEDAAF80CQ42353279-A24F6C63-17A4-4F10-A77E-A742CEE8561BQ42475393-102E6C49-F28E-460B-AB7F-8212C3E7919DQ42480186-1406A788-68D6-4325-BBCF-AE9CA728FCDFQ42485824-7EEE0ABF-AB79-4177-BCF6-5943DB453C01Q42522644-226C26A9-B9E8-4FBA-AA44-0C82DC8C66DDQ43280338-C9B0054C-A43B-4BCE-B4EA-06A1ADD6C43BQ44579266-4D629346-6A21-4E9C-A04B-3C72953D2090Q45005527-158E0D43-FEC2-4823-A92B-684359274623Q46463770-F1951A3C-550D-41DD-AC8F-2CB0DAFA78D4Q46737950-77058229-81FC-43C5-9BA7-CC95E70D0670Q47098333-F8F6055D-5E33-4DB1-982F-52ADBD3E30D1Q47258866-D0833DDB-144F-420A-82BB-229DCE47F9F3Q47821161-A5080B60-82C0-4E08-801F-8790EC64D4A4
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Semir Vranic
@ast
Semir Vranic
@en
Semir Vranic
@es
Semir Vranic
@nl
Semir Vranic
@sl
type
label
Semir Vranic
@ast
Semir Vranic
@en
Semir Vranic
@es
Semir Vranic
@nl
Semir Vranic
@sl
altLabel
Semir Vranić
@en
prefLabel
Semir Vranic
@ast
Semir Vranic
@en
Semir Vranic
@es
Semir Vranic
@nl
Semir Vranic
@sl
P214
P244
P106
P108
P1153
6506742049
P21
P214
P244
nb2007025509
P2798
P31
P3835
semir-vranic
P496
0000-0001-9743-7265
P569
2000-01-01T00:00:00Z
P735
P7859
lccn-nb2007025509